FAFGX has more cash in the bank: 357B vs. ACGRX (198M). FAFGX pays higher dividends than ACGRX: FAFGX (0.45) vs ACGRX (0.00). ACGRX was incepted earlier than FAFGX: ACGRX (2 years) vs FAFGX (6 years). ACGRX (1.86) is less costly to investors than FAFGX (0.38). FAFGX is a more actively managed with annual turnover of: 32.00 vs. ACGRX (6.74). FAFGX has a lower initial minimum investment than ACGRX: FAFGX (250) vs ACGRX (2500). ACGRX annual gain was more profitable for investors over the last year : 16.94 vs. FAFGX (6.21).

	ACGRX	FAFGX	ACGRX / FAFGX
Total Expense Ratio	1.86	0.38	489%
Annual Report Gross Expense Ratio	1.86	0.38	489%
Fund Existence	2 years	6 years	-
Gain YTD	9.628	10.178	95%
Front Load	N/A	N/A	-
Min. Initial Investment	2500	250	1,000%
Min. Initial Investment IRA	N/A	N/A	-
Net Assets	198M	357B	0%
Annual Yield % from dividends	0.00	0.45	-
Returns for 1 year	16.94	6.21	273%
Returns for 3 years	N/A	44.93	-
Returns for 5 years	N/A	18.78	-
Returns for 10 years	N/A	N/A	-

View a ticker or compare two or three

Ask AI

Compare

Interact to see
Advertisement

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
MOVE	12.96	0.82	+6.75%
Corvex Inc.
SNDX	20.40	0.64	+3.24%
Syndax Pharmaceuticals
KYMR	107.52	1.11	+1.04%
Kymera Therapeutics
GRCE	2.13	0.01	+0.47%
Grace Therapeutics Inc
RFAMU	10.00	N/A	N/A
RF Acquisition Corp III